Skip to main content
. 2023 Oct 13;8:392. doi: 10.1038/s41392-023-01636-9

Fig. 1.

Fig. 1

CONSORT diagram of the study. Out of the 32 patients initially screened, 29 were enrolled to receive sintilimab treatment. The study utilized the standard 3 + 3 design. DLT represents dose-limiting toxicity